Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 15 » Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus
Please verify you are not a robot.